Hatteras Venture Partners

Hatteras Venture Partners is a venture capital firm based in Durham, North Carolina, focusing on early-stage investments in the life sciences and healthcare sectors. Established in 2000, the firm has managed over $900 million across multiple funds, supporting companies in biotechnology, medical devices, and health technology. Their mission is to build transformational human medicine companies that benefit patients and the professionals who serve them.

The firm's investment strategy centers on seed and early-stage opportunities, aiming to foster innovation and growth in the healthcare industry. They provide strategic guidance and financial support to promising startups, assisting them in navigating the complexities of the healthcare market. Hatteras has a history of successful investments, including companies like HistoSonics, Inc., Kymera Therapeutics, Inc., and G1 Therapeutics, Inc., which have achieved significant milestones such as FDA approvals and successful IPOs.

Hatteras Venture Partners is led by a seasoned team of entrepreneurs and operators with a proven track record in seed and early-stage investing and company formation. They actively participate in the life sciences community by collaborating with other venture firms, academic institutions, and industry experts, contributing to the advancement of innovative solutions that address critical healthcare challenges and improve patient outcomes.